MaxCyte, Inc.
MXCT
$1.27
$0.032.42%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -13.15% | -14.30% | -14.50% | -24.52% | -21.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -13.15% | -14.30% | -14.50% | -24.52% | -21.32% |
| Cost of Revenue | -10.73% | -12.51% | -12.37% | 7.84% | 37.44% |
| Gross Profit | -13.77% | -14.73% | -14.98% | -29.79% | -29.00% |
| SG&A Expenses | -31.21% | -25.90% | -17.62% | -11.03% | -4.00% |
| Depreciation & Amortization | -3.06% | 1.09% | 2.00% | 0.45% | -0.38% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.48% | -20.31% | -13.50% | -7.85% | -2.91% |
| Operating Income | 35.42% | 24.74% | 12.73% | -8.53% | -15.17% |
| Income Before Tax | 20.41% | 6.39% | -8.71% | -27.69% | -26.37% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 20.41% | 6.39% | -8.71% | -27.69% | -26.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.41% | 6.39% | -8.71% | -27.69% | -26.37% |
| EBIT | 35.42% | 24.74% | 12.73% | -8.53% | -15.17% |
| EBITDA | 38.20% | 26.96% | 13.93% | -9.52% | -16.88% |
| EPS Basic | 21.12% | 7.54% | -7.10% | -25.67% | -24.21% |
| Normalized Basic EPS | 37.18% | 24.57% | 10.14% | -16.89% | -23.76% |
| EPS Diluted | 21.12% | 7.54% | -7.10% | -25.67% | -24.21% |
| Normalized Diluted EPS | 37.18% | 24.57% | 10.14% | -16.89% | -23.76% |
| Average Basic Shares Outstanding | 0.95% | 1.28% | 1.51% | 1.67% | 1.71% |
| Average Diluted Shares Outstanding | 0.95% | 1.28% | 1.51% | 1.67% | 1.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |